Metromedi Health Technologies Private Limited, a active private limited company, was established on 20 March 2018 in Manikonda, Telangana, India. Engaging in online healthcare product retail within the trade sector, it holds CIN: U52609TG2018PTC123145. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.83 Cr.
Formerly known as Medrem Pharma Private Limited. Its leadership includes Dileep Byra Chakravarthy (Managing Director), Janaki Chakravarthi Byra (Director). Past directors included Mahipal Reddy Saddi, Dileep Byra Chakravarthy, Darshan Kumar Kulkarni. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.74, 1St Floor Tanesha Nagar, Manikonda, Telangana, 500089.
U52609TG2018PTC123145
123145
20 March 2018
₹11.00 Cr
₹10.83 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Metromedi Health Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dileep Byra Chakravarthy | Managing Director | 28 Nov 2018 | Current |
| Janaki Chakravarthi Byra | Director | 20 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 17 Jan 2019 | Past |
| Pramod Abcsdd | Director | 28 Nov 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Metromedi Health Technologies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.69% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth moved up by a moderate rise of 0.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Metromedi Health Technologies had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹2.00 Cr | Open |
| 18 Dec 2020 | Others | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Metromedi Health Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Metromedi Health Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metromedi Health Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Metromedi Health Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Metromedi Health Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100549425 was registered on 16 Mar 2022. was completed.
Progress on A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100398121 was registered on 18 Dec 2020. was documented.
The activity Dileep Byra Chakravarthy was appointed as a Managing Director was appointed as a Managing Director on 28 Nov 2018 & has been associated with this company since 7 years 16 days . was completed.
Progress on Janaki Chakravarthi Byra was appointed as a Director was appointed as a Director on 20 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
The CIN of Metromedi Health Technologies Private Limited is U52609TG2018PTC123145.
Metromedi Health Technologies Private Limited is headquartered at Plot No.74, 1St Floor Tanesha Nagar, Manikonda, Telangana, 500089.
Metromedi Health Technologies Private Limited was incorporated on 20 March 2018.
The current directors of Metromedi Health Technologies Private Limited are
The primary industry of Metromedi Health Technologies Private Limited is Trade.
Metromedi Health Technologies Private Limited is unlisted.
The authorized capital of Metromedi Health Technologies Private Limited is ₹11.00 Cr, and the paid-up capital is ₹10.83 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX